Filing Flows › Bristol Myers Squibb (BMY) › Net product sales revenue
Bristol Myers Squibb (BMY) Net product sales revenue by quarter
Bristol Myers Squibb's Net product sales revenue was $12.6B in Q3 2026 (third quarter 2026), +0.2% from Q2 2026. Over the last 7 quarters it ranged from $10.9B (Q1 2025) to $12.6B (Q3 2026).
| Quarter | Net product sales revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $12.6B | +0.2% | +7% |
| Q2 2026 | $12.6B | +13% | +6% |
| Q1 2026 | $11.2B | -8% | +2% |
| Q4 2025 | $12.1B | +2% | — |
| Q3 2025 | $11.8B | -0.6% | — |
| Q2 2025 | $11.9B | +9% | — |
| Q1 2025 | $10.9B | — | — |
Q3 2026 at a glance
Bristol Myers Squibb, Q3 2026: revenue $13.1B (+7% year over year), operating margin 19.4%, net earnings $2.2B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Bristol Myers Squibb's Net product sales revenue?
Bristol Myers Squibb's Net product sales revenue was $12.6B in Q3 2026 (third quarter 2026), +0.2% from Q2 2026.
How has Bristol Myers Squibb's Net product sales revenue changed?
Over the last 7 quarters it ranged from $10.9B (Q1 2025) to $12.6B (Q3 2026).